Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Donors on most medications can donate certain blood products without waiting, except for specific drugs that need a waiting period.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Blocking interferon-gamma might help treat various autoimmune diseases.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Afatinib often causes skin problems that need proactive management.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

The document summarized how various modern drugs are made.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.